The Coronavirus Vaccine, cataloged under National Stock Number 6505-01-734-5678, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Moderna Us, Inc.. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.
| Parameter | Value |
|---|---|
| NSN | 6505-01-734-5678 |
| Primary Part Number | NDC80777-0112-96 |
| Item Name | Coronavirus Vaccine |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Moderna Us, Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 0.5 MILLILITERS |
| Virus Strain | COVID-19 |
| Primary Container Type | SYRINGE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BX |
| Part Number | Manufacturer |
|---|---|
| NDC80777-0112-96 PRIMARY | Moderna Us, Inc. (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM252108 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1709475 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-734-5678 is a Coronavirus Vaccine, manufactured by Moderna Us, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-734-5678 has 1 manufacturer part number on file: NDC80777-0112-96 (Moderna Us, Inc.).
Key specifications for NDC80777-0112-96: Primary Container Content Quantity: 0.5 MILLILITERS; Virus Strain: COVID-19; Primary Container Type: SYRINGE; Special Features: INDICATED FOR ACTIVE IMMUNIZATION TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARSCOV-2) IN INDIVIDUALS 6 MONTHS THROUGH 64 YEARS OF AGE WITH AT LEAST ONE UNDERLYING CONDITION THAT PUTS THEM AT HIGH RISK FOR SEVERE OUTCOMES FROM COVID-19 OR 65 YEARS AND OLDER; INJECTABLE SUSPENSION, FOR INTRAMUSCULAR USE; BOX OF 10 SINGLE DOSE PRE-FILLED SYRINGES, EACH SYRINGE CONTAINING 1 DOSE OF 0.5ML; STORE FROZEN BETWEEN -50 C TO -15 C (-58 F TO 5 F). AFTER THAWING, MAY BE STORED REFRIGERATED BETWEEN 2 C TO 8 C (36 F TO 46 F) FOR UP TO 60 DAYS OR UP TO THE EXPIRATION DATE PRINTED ON THE BOX, WHICHEVER COMES FIRST; MINIMIZE EXPOSURE TO ROOM LIGHT, AND AVOID EXPOSURE TO DIRECT SUNLIGHT AND ULTRAVIOLET LIGHT; DO NOT REFREEZE ONCE THAWED. 2025-2026 FORMULA.. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.